Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:64-71

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laws, A.
Right arrow Articles by Howard, B.V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laws, A.
Right arrow Articles by Howard, B.V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:64-71.)
© 1997 American Heart Association, Inc.


Articles

Differences in Insulin Suppression of Free Fatty Acid Levels by Gender and Glucose Tolerance Status

Relation to Plasma Triglyceride and Apolipoprotein B Concentrations

A. Laws; H.M. Hoen; J.V. Selby; M.F. Saad; S.M. Haffner; B.V. Howard; for the Insulin Resistance Atherosclerosis Study (IRAS) Investigators

the Department of Medicine (A.L.), Stanford University, Stanford, Calif; the Department of Public Health Sciences (H.M.H), Bowman Gray School of Medicine, Winston-Salem, NC; the Medlantic Research Institute (B.V.H.), Washington, DC; the Division of Research (J.V.S.), Kaiser Permanente, Oakland, Calif; the Department of Medicine (S.M.H.), University of Texas Health Science Center at San Antonio; and the Department of Medicine (M.F.S.), University of Southern California, Los Angeles.

Correspondence to Ami Laws, MD, Stanford Medical Group, 900 Blake Wilbur Dr, Suite W2080, Stanford University, Stanford, CA 94305-2205.

Most discussions of relations of insulin resistance to coronary heart disease risk factors have focused on insulin-stimulated glucose uptake, but insulin suppression of plasma free fatty acid (FFA) levels is also important in lipid and lipoprotein metabolism. To identify groups with impaired insulin suppression of FFAs, we studied a multiethnic cohort of 1521 women and men at four US centers that comprise the Insulin Resistance Atherosclerosis Study (IRAS): 682 with normal glucose tolerance, 352 with impaired glucose tolerance, and 487 with non–insulin-dependent diabetes. The FFA level 2 hours after a 75-gm oral glucose load adjusted for fasting FFAs was used as the measure of insulin suppression. After adjustment for age, center, ethnicity, body mass index, and fasting and 2-hour insulin levels, 2-hour FFA levels were significantly higher in men than women and in persons with impaired glucose tolerance and non–insulin-dependent diabetes mellitus versus normal glucose tolerance. The gender difference was largely accounted for by differences in central obesity as measured by waist-hip ratio; the difference by glucose tolerance status was not affected by central obesity, suggesting a different mechanism. In multivariate regression analyses, 2-hour FFA levels were strongly related to fasting triglyceride and apoB levels, respectively, after adjustment for age, fasting and 2-hour insulin concentrations, and fasting FFA concentrations. In summary, elevated plasma apoB and triglyceride concentrations associated with male gender and with glucose intolerance are partly accounted for by differences in the ability of insulin to suppress FFA concentrations.


Key Words: free fatty acids • gender • insulin resistance • triglycerides • apolipoprotein B




This article has been cited by other articles:


Home page
DiabetesHome page
J. M. Stafford, F. Yu, R. Printz, A. H. Hasty, L. L. Swift, and K. D. Niswender
Central Nervous System Neuropeptide Y Signaling Modulates VLDL Triglyceride Secretion
Diabetes, June 1, 2008; 57(6): 1482 - 1490.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. L. Wang, L. Zhang, K. Youker, M.-X. Zhang, J. Wang, S. A. LeMaire, J. S. Coselli, and Y. H. Shen
Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase.
Diabetes, August 1, 2006; 55(8): 2301 - 2310.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Myerson, C. Ngai, J. Jones, S. Holleran, R. Ramakrishnan, L. Berglund, and H. N. Ginsberg
Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia
J. Lipid Res., December 1, 2005; 46(12): 2735 - 2744.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
X. Ma, S. Bacci, W. Mlynarski, L. Gottardo, T. Soccio, C. Menzaghi, E. Iori, R. A. Lager, A. R. Shroff, E. V. Gervino, et al.
A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians
Hum. Mol. Genet., October 1, 2004; 13(19): 2197 - 2205.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Iozzo, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti
Effect of Training Status on Regional Disposal of Circulating Free Fatty Acids in the Liver and Skeletal Muscle During Physiological Hyperinsulinemia
Diabetes Care, September 1, 2004; 27(9): 2172 - 2177.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
M. E. Valera Mora, A. Scarfone, M. Calvani, A. V. Greco, and G. Mingrone
Insulin Clearance in Obesity
J. Am. Coll. Nutr., December 1, 2003; 22(6): 487 - 493.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. Chen, D. B. Jump, M. B. Grant, W. J. Esselman, and J. V. Busik
Dyslipidemia, but Not Hyperglycemia, Induces Inflammatory Adhesion Molecules in Human Retinal Vascular Endothelial Cells
Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 5016 - 5022.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. J.G. Hanley, L. E. Wagenknecht, R. B. D'Agostino Jr., B. Zinman, and S. M. Haffner
Identification of Subjects with Insulin Resistance and {beta}-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome
Diabetes, November 1, 2003; 52(11): 2740 - 2747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
T. M. Wolever and C. Mehling
Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance
Am. J. Clinical Nutrition, March 1, 2003; 77(3): 612 - 621.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Shah, A. Vella, A. Basu, R. Basu, A. Adkins, W. F. Schwenk, C. M. Johnson, K. S. Nair, M. D. Jensen, and R. A. Rizza
Elevated Free Fatty Acids Impair Glucose Metabolism in Women: Decreased Stimulation of Muscle Glucose Uptake and Suppression of Splanchnic Glucose Production During Combined Hyperinsulinemia and Hyperglycemia
Diabetes, January 1, 2003; 52(1): 38 - 42.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
L. P. Palaniappan, M. R. Carnethon, and S. P. Fortmann
Heterogeneity in the Relationship Between Ethnicity, BMI, and Fasting Insulin
Diabetes Care, August 1, 2002; 25(8): 1351 - 1357.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Galipeau, L. Yao, and J. H. McNeill
Relationship among hyperinsulinemia, insulin resistance, and hypertension is dependent on sex
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H562 - H567.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. J.G. Hanley, R. D'Agostino Jr., L. E. Wagenknecht, M. F. Saad, P. J. Savage, R. Bergman, and S. M. Haffner
Increased Proinsulin Levels and Decreased Acute Insulin Response Independently Predict the Incidence of Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study
Diabetes, April 1, 2002; 51(4): 1263 - 1270.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. D. Sniderman, T. Scantlebury, and K. Cianflone
Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus
Ann Intern Med, September 18, 2001; 135(6): 447 - 459.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. P. Frias, G. B. Macaraeg, J. Ofrecio, J. G. Yu, J. M. Olefsky, and Y. T. Kruszynska
Decreased Susceptibility to Fatty Acid-Induced Peripheral Tissue Insulin Resistance in Women
Diabetes, June 1, 2001; 50(6): 1344 - 1350.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Hulthe, L. Bokemark, J. Wikstrand, and B. Fagerberg
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis : The Atherosclerosis and Insulin Resistance (AIR) Study
Arterioscler. Thromb. Vasc. Biol., September 1, 2000; 20(9): 2140 - 2147.
[Abstract] [Full Text] [PDF]